BCM
CLVS

Bluefin Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bluefin Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-66,752
Closed -$425K – 503
2020
Q1 		$425K Buy
+66,752
New +$535K 0.05% 187

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bluefin Capital Management's CLVS Position: Q2 2020 in Review

Bluefin Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 66,752 shares — an estimated $425K sold.

Bluefin Capital Management first reported a position in CLVS in Q1 2020 and held it in 1 quarter. The position peaked at $425K in Q1 2020. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Bluefin Capital Management reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 66,752 Clovis Oncology, Inc. shares in Q2 2020, an estimated $425K.
  • Bluefin Capital Management first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 1 quarter.
  • Bluefin Capital Management's Clovis Oncology, Inc. position peaked at $425K in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Bluefin Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.